Warfarin and Its Effect on Cancer Metastasis
Author Information
Author(s): P. McCulloch, W.D. George
Primary Institution: University Department of Surgery, Western Infirmary, Glasgow, UK
Hypothesis
Does warfarin inhibit metastasis of Mtln3 rat mammary carcinoma without affecting primary tumor growth?
Conclusion
Warfarin can inhibit metastasis in an animal model of cancer without directly or indirectly inhibiting the growth of the primary tumor.
Supporting Evidence
- Warfarin treatment significantly reduced the number of pulmonary metastases in treated rats compared to controls.
- Warfarin had no discernible effect on the growth of Mtln3 mammary carcinoma cells in vitro at concentrations below 1 mM.
- The mean plasma warfarin concentration in treated rats was 1.63 µM.
Takeaway
Warfarin is a medicine that can help stop cancer from spreading in rats, but it doesn't make the main tumor grow slower.
Methodology
The study involved in vitro cytotoxicity tests and in vivo experiments on Fischer 344 rats to assess the effects of warfarin on tumor growth and metastasis.
Potential Biases
The study design may have inherent biases due to the monitoring and treatment of the rats.
Limitations
The study had a high mortality rate among rats due to bleeding, which may affect the interpretation of results.
Participant Demographics
Female Fischer 344 rats, 6-8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website